Elevated circulating levels of SELENOP have been observed in obese individuals [57], and a deficiency in Selenof [58], Selenom [59], Selenos [60], Selenot [61], or Selenov [62] has been shown to lead to lipid metabolic disorder in established mouse models and usually exacerbates HFD-induced lipid accumulation in the body. This evidence concerns the gene SELENOP and Disorder of lipid metabolism.